Cargando…
COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation
‘Renaissance took place in Chaos and plague’. It was COVID-19 pandemic, when world realized ayurveda co-interventions are praiseworthy even in acute, infective and fatal conditions like COVID-19. We report perhaps first case of COVID-19 patient with cancer managed with poly-herbal ayurvedic formulat...
Autores principales: | Dilip Pandkar, Prasad, Deshmukh, Santosh Raosaheb, Sachdeva, Vinay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372187/ https://www.ncbi.nlm.nih.gov/pubmed/35975131 http://dx.doi.org/10.1016/j.jaim.2022.100632 |
Ejemplares similares
-
Pathophysiology of Covid-19 and host centric approaches in Ayurveda
por: Pandkar, Prasad Dilip, et al.
Publicado: (2022) -
Multimodal ayurvedic approach in the management of moderate SARS-COV2 infection with co-morbidities – A case report
por: Mythri, H. S., et al.
Publicado: (2022) -
Analytical profile of Brahmi Ghrita: A polyherbal Ayurvedic formulation
por: Gubbannavar, Jyoti S., et al.
Publicado: (2012) -
Preliminary Screening of a Classical Ayurvedic Formulation for Anticonvulsant Activity
por: Dhar, Arnab, et al.
Publicado: (2016) -
Ayurvedic formulations: Potential COVID-19 therapeutics?
por: Mahaboob Ali, Anees Ahmed, et al.
Publicado: (2022)